Home > Products > CD28 & MUC1
> Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (scIgG)
Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (scIgG) (CAT#: SCIGG-062)
Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD28 and anti-MUC1 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Pancreatic cancer; Ovarian cancer; Breast cancer; Bile duct cancer (BDC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (scIgG) (SCIGG-062). Click the button below to contact us or submit your feedback about this product.